Pyxis Oncology, Inc.·4

Mar 28, 4:41 PM ET

Civik Thomas 4

4 · Pyxis Oncology, Inc. · Filed Mar 28, 2023

Insider Transaction Report

Form 4
Period: 2023-03-24
Civik Thomas
DirectorInterim CEO
Transactions
  • Award

    Common Stock

    2023-03-24+139,355206,186 total
Holdings
  • Common Stock

    (indirect: By Trust)
    15,700
Footnotes (2)
  • [F1]Represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.
  • [F2]These shares are held directly by the Civik Family Trust, a revocable trust for which the Reporting Person and his spouse are the grantors.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION